Text Size
20 studies found for:    "Diabetes Insipidus, Neurogenic" [DISEASE]

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Completed Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus
Conditions: Diabetes Insipidus;   Diabetes Insipidus, Neurohypophyseal
Interventions: Drug: chlorpropamide;   Drug: desmopressin
2 Completed Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
Condition: Nephrogenic Diabetes Insipidus
Interventions: Drug: sildenafil;   Drug: calcitonin;   Drug: hydrochlorothiazide/amiloride;   Drug: indomethacin;   Drug: Placebo for sildenafil;   Drug: placebo for calcitonin
3 Recruiting Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study
Condition: Diabetes Insipidus
Intervention:
4 Unknown † Study of Novel Types of Familial Diabetes Insipidus
Condition: Diabetes Insipidus
Intervention: Drug: desmopressin
5 Completed Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
Condition: Diabetes Insipidus, Nephrogenic
Intervention: Drug: chlorothiazide
6 Completed A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).
Condition: Central Diabetes Insipidus
Interventions: Drug: Desmopressin Oral Melt;   Drug: Desmopressin intranasal
7 Completed Vasopressin Deficiency in Hemorrhagic Shock
Condition: Body Response to Trauma
Intervention: Other: Phlebotomy
8 Recruiting Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
Conditions: Chronic Hepatitis C;   Chronic Hepatitis B;   Biopsy;   Hemodialysis
Intervention: Procedure: Percutaneous liver biopsy
9 Completed Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Conditions: Inappropriate ADH Syndrome;   Hyponatremia
Intervention: Drug: SR121463B
10 Completed Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Conditions: Inappropriate ADH Syndrome;   Hyponatremia
Intervention: Drug: SR121463B
11 Completed Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Conditions: Syndrome of Inappropriate ADH (SIADH) Secretion;   Hyponatremia
Intervention: Drug: satavaptan (SR121463B)
12 Completed The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration
Condition: Exercise Induced Hyponatremia
Interventions: Dietary Supplement: Gatorade Endurance Formula;   Other: ganirelix acetate
13 Not yet recruiting AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock
Condition: Traumatic Shock
Intervention: Drug: Vasopressin
14 Recruiting Oxytocin and Arginine Vasopressin in Pain Relief
Condition: Placebo Analgesia
Intervention:
15 Completed 1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy
Condition: Kidney Failure
Interventions: Drug: DDAVP;   Drug: placebo
16 Unknown † GLP Analogs for Diabetes in Wolfram Syndrome Patients
Conditions: Diabetes Mellitus Associated With Genetic Syndrome;   Wolfram Syndrome
Intervention: Drug: Exenatide
17 Completed The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)
Conditions: Stroke;   Transient Ischemic Attack
Intervention:
18 Recruiting Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis
Condition: Pituitary Adenoma
Intervention:
19 Completed Electrolyte and Fluid Disturbances in Subarachnoid Hemorrhage and Traumatic Brain Injury
Conditions: Electrolyte Disturbances;   Subarachnoid Hemorrhage;   Traumatic Brain Injury;   Natriuretic Peptides
Intervention:
20 Completed Copeptin in Differentiation of Polyuria and Polydipsia
Conditions: Polyuria;   Polydipsia
Intervention:
To Top

† Indicates status has not been verified in more than two years